Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOGEN INC. | 470,278 | reported | 03 Jun 2009 | tx 106+338,345−960,220 |
| Syros Pharmaceuticals, Inc. | 11,000 | reported | 11 Jun 2019 | tx 13+332,666−1,000,000 |
| ALNYLAM PHARMACEUTICALS, INC. | 9,000 | reported | 01 Jul 2019 | tx 76+1,388,328−1,292,061 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2019 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9,000 | 0.00 USD | deriv |
| 11 Jun 2019 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11,000 | 0.00 USD | deriv |
| 15 Apr 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 400 | 89.97 USD | |
| 15 Apr 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,200 | 89.03 USD | |
| 15 Apr 2019 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 22.09 USD | |
| 15 Apr 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 600 | 91.40 USD | |
| 15 Apr 2019 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 11,800 | 87.86 USD | |
| 15 Apr 2019 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 20 Jun 2018 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9,000 | 0.00 USD | deriv |
| 14 Jun 2018 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11,000 | 0.00 USD | deriv |
| 13 Mar 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 21.35 USD | |
| 13 Mar 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 149.00 USD | |
| 13 Mar 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 09 Mar 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 129.00 USD | |
| 09 Mar 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 27.28 USD | |
| 09 Mar 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 08 Jun 2017 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 11,000 | 0.00 USD | deriv |
| 02 Jun 2017 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 11,250 | 0.00 USD | deriv |
| 01 Feb 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 4,829 | 40.16 USD | |
| 01 Feb 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 25,000 | 31.29 USD | |
| 01 Feb 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 20,171 | 39.72 USD | |
| 01 Feb 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 25,000 | 0.00 USD | deriv |
| 25 Jan 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 31.39 USD | |
| 25 Jan 2017 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 37.95 USD | |
| 25 Jan 2017 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |